- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 3.79M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $20.43M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $17.61M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $3.45M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $6.4M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $20.07M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $22.87M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $54.76M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $55.19M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $96.85M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $95.46M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $162.17M |
| Total Assets | Q1 2025 · Mar 31, 2024 | $159.38M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 4.21M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $561K |
| Capex | Q1 2025 · Mar 31, 2024 | $1.61M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$10.17M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $99.09M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $97.9M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.39 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.45 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $14.84M |
| Net Income | Q1 2025 · Mar 31, 2024 | $1.64M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $2.56M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $17.4M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $27.56M |
| Revenue | Q1 2025 · Mar 31, 2024 | $44.96M |